Beij Astrid, Verdonk Robert C, van Santvoort Hjalmar C, de-Madaria Enrique, Voermans Rogier P
Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, Location University of Amsterdam, Amsterdam, the Netherlands.
Department of Research and Development, St. Antonius Hospital, Nieuwegein, the Netherlands.
United European Gastroenterol J. 2025 Feb;13(1):97-106. doi: 10.1002/ueg2.12743. Epub 2025 Jan 13.
Acute pancreatitis is a common gastrointestinal disease leading to hospitalisation. Recent advancements in its management have primarily focussed on the development of early phase medical interventions targeting inflammatory pathways, optimisation of supportive treatment (including fluid resuscitation, pain management and nutritional management), appropriate use of antibiotics, implementation of minimally invasive interventions for infected necrosis, and the necessity of follow-up for long-term complications. These advancements have significantly improved personalised management and overall outcomes of acute pancreatitis. Despite these efforts, early-phase medical interventions to mitigate disease progression are still lacking and acute pancreatitis remains a heterogeneous disease. Future research and clinical trials are imperative to further optimise current strategies and develop new therapeutic approaches. This review presents an evidence-based approach to the management of acute pancreatitis, highlighting recent developments.
急性胰腺炎是一种常见的导致住院的胃肠道疾病。其治疗方面的最新进展主要集中在针对炎症途径的早期医学干预措施的开发、支持性治疗的优化(包括液体复苏、疼痛管理和营养管理)、抗生素的合理使用、对感染性坏死实施微创干预以及对长期并发症进行随访的必要性。这些进展显著改善了急性胰腺炎的个性化管理和总体治疗效果。尽管做出了这些努力,减轻疾病进展的早期医学干预措施仍然不足,且急性胰腺炎仍是一种异质性疾病。未来的研究和临床试验对于进一步优化当前策略及开发新的治疗方法至关重要。本综述介绍了一种基于证据的急性胰腺炎管理方法,并突出了近期的进展。